GIP/GLP-1 Co-Activity in Subjects With Obesity: Lowering of Food Intake (GASOLIN)

Clinical Trial ID NCT02598791

PubWeight™ 0.00‹?›

🔗 Visit the ClinicalTrials.gov page for NCT02598791

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Glucagon-like peptide 1 promotes satiety and suppresses energy intake in humans. J Clin Invest 1998 3.18
2 Pharmacology, physiology, and mechanisms of incretin hormone action. Cell Metab 2013 2.60
3 Unimolecular dual incretins maximize metabolic benefits in rodents, monkeys, and humans. Sci Transl Med 2013 1.72
4 Glucose-dependent insulinotropic polypeptide inhibits bone resorption in humans. J Clin Endocrinol Metab 2014 0.89
Next 100